Comparative impact of treatment on patient reported outcomes (PROs) in patients with glioblastoma (GBM) enrolled in RTOG 0825.
Terri S. Armstrong
Honoraria - Merck
Research Funding - Genentech
Minhee Won
No relevant relationships to disclose
Jeffrey Scott Wefel
Consultant or Advisory Role - Genentech; Roche
Mark R. Gilbert
Consultant or Advisory Role - Genentech; Merck
Honoraria - Merck
Research Funding - Genentech; GlaxoSmithKline
Stephanie L. Pugh
No relevant relationships to disclose
David Brachman
No relevant relationships to disclose
Ritsuko Komaki
No relevant relationships to disclose
Ian R. Crocker
No relevant relationships to disclose
H. Ian Robins
Consultant or Advisory Role - Genentech
R. Jeffrey Lee
No relevant relationships to disclose
Minesh P. Mehta
Consultant or Advisory Role - Genentech; Merck
Stock Ownership - Accuray
Honoraria - Merck
Merideth M Wendland
No relevant relationships to disclose